CCND1 and hepatocellular carcinoma: Then, the underlying molecular mechanism of miR-655-3p inhibiting HCC progress was detected, and the results showed upregulating miR-655-3p expression increased E-cadherin protein but decreased the nucleus β-catenin, cyclinD1 and c-myc expression.